Pathway Therapeutics' Series A - III Round

Pathway Therapeutics raised a round of funding on October 07, 2009.

Pathway Therapeutics is a clinical stage, privately held, pharmaceutical company developing differentiated isoform specific PI3-kinase (PI3K) inhibitors for oncology, inflammatory and respiratory dise…

Articles about Pathway Therapeutics' Series A - III Round: